Cargando…
Dietary Compound Isoliquiritigenin, an Antioxidant from Licorice, Suppresses Triple-Negative Breast Tumor Growth via Apoptotic Death Program Activation in Cell and Xenograft Animal Models
Patients with triple-negative breast cancer have few therapeutic strategy options. In this study, we investigated the effect of isoliquiritigenin (ISL) on the proliferation of triple-negative breast cancer cells. We found that treatment with ISL inhibited triple-negative breast cancer cell line (MDA...
Autores principales: | Lin, Po-Han, Chiang, Yi-Fen, Shieh, Tzong-Ming, Chen, Hsin-Yuan, Shih, Chun-Kuang, Wang, Tong-Hong, Wang, Kai-Lee, Huang, Tsui-Chin, Hong, Yong-Han, Li, Sing-Chung, Hsia, Shih-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139602/ https://www.ncbi.nlm.nih.gov/pubmed/32164337 http://dx.doi.org/10.3390/antiox9030228 |
Ejemplares similares
-
Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer
por: Chen, Hsin-Yuan, et al.
Publicado: (2021) -
Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth
por: Chen, Hsin-Yuan, et al.
Publicado: (2017) -
Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice
por: Wu, Chi-Hao, et al.
Publicado: (2016) -
Recent Advances in Glycyrrhiza glabra (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment
por: Wang, Kai-Lee, et al.
Publicado: (2022) -
Perspectives on the Role of Isoliquiritigenin in Cancer
por: Wang, Kai-Lee, et al.
Publicado: (2021)